Apricus Biosciences Announces Formation Of Clinical Advisory Board As Part Of Its Plans To Further The Clinical Development Of Femprox(R)
Dr. Jed Kaminetsky, M.D. is a Clinical Associate Professor at New York University Medical Center and is a practicing urologist with University Urology Associates, one of the largest urologic practices in the New York City metropolitan area. He is a reputable urologist and is highly skilled in treating all urologic disorders and performing minimally invasive prostate surgeries. Dr. Kaminetsky's academic interests include the study of both male and female sexual dysfunction, which has led him to become a national and world thought leader. Dr. Kaminetsky's work has been published in several journals which led to a nationwide recognition and development of various treatment schemes for patients with sexual and erectile dysfunction, including the creation of Dream Cream, a topical formulation for the treatment of female sexual dysfunction. Moreover, Dr. Kaminetsky is an experienced principal investigator who participates in national research studies that explore pharmacologic and diagnostic techniques for various urologic disorders. He is currently conducting studies addressing premature ejaculation, ED, male and female sexual dysfunction, UTIs, BPH, acute pyelonephritis, chronic non-bacterial prostatitis, prostate cancer, voiding dysfunction, treatment and prevention of stone disease, and hypergonadism. His hospital appointments include New York University Medical Center, New York Downtown Medical Center, Saint Vincent's Hospital, and Saint Vincent's Catholic Medical Center. Dr. Kaminetsky has been consulting for several pharmaceutical companies including Bayer Corporation, UNIMED Pharmaceuticals, Pharmacia Corporation, Schering-Plough and Vivus, Inc.
Dr. Ajay Nehra, M.D. is a Professor of Urology at the Mayo Medical School, and a consultant in the Department of Urology of the Mayo Clinic, both in Rochester, MN. He received his medical degree from the All India Institute of Medical Sciences in New Delhi, and served his residency at the Boston University School of Medicine, and a residency and chief residency at Maimonides Medical Center in Brooklyn, N.Y. Dr. Nehra has been the principal investigator with more than seven clinical multicenter investigational studies of the efficacy and safety of a number of treatments for erectile dysfunction. He is a co-investigator in the National Institutes of Health program project on aging. Dr. Nehra has contributed more than 100 articles and 120 abstracts, mainly on male sexual dysfunction, male infertility, neuro-urology, prosthetics, urologic oncology and BPH. He has also written ED-related chapters of books and he has co-authored a book of commentary on sexual dysfunction in medicine. Dr. Nehra is a former President of the Sexual Medicine Society of North America, a board member of the American Urological Association and many national and international professional societies. Dr Nehra is a thought leader and consultant for many pharmaceutical companies including, GlaxoSmithKline, Pfizer, and Sanofi-Aventis.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
